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ABSTRACT One of the least well understood problems in cancer chemotherapy is the cross-resistance of certain tumor
cells to a series of chemically unrelated drugs. Multidrug resistance (MDR) can be attributed to several different biophysical
processes, among them increased drug efflux. This has been found to correlate with overexpression of the cell surface
170-kDa P-glycoprotein that actively excludes cytotoxic drugs against their concentration gradient. To better understand
MDR, experimental methods are needed to study drug efflux from cancer cells. Continuous measurement of efflux of
nonfluorescent drugs on the same cell culture in situ, or assessing efflux from a few cells or even a single cell, is beyond the
capabilities of existing technologies. In this work, a carbon fiber (CF) microelectrode is used to monitor efflux of doxorubicin
from a monolayer of two cell lines: an auxotrophic mutant of Chinese hamster ovary cells, AUXB1, and its MDR subline,
CHRC5. Because doxorubicin is both fluorescent and electroactive, the results could be validated against existing data
obtained optically and with other techniques on the same cell lines, with good agreement found. The electrochemical
detection, however, is capable of in situ monitoring with high temporal resolution and is suitable for single-cell studies.
INTRODUCTION
One of the least well understood problems in cancer che-
motherapy is the eventual resistance of tumor cells to dif-
ferent chemotherapeutic drugs of natural product origin,
such as doxorubicin, actinomycin D, vinblastine, vincris-
tine, or colchinine. Increasing the concentrations of these
agents in small consecutive steps results in high-level cross-
resistance in such cells to them as well as to many other,
chemically unrelated drugs which, nevertheless, tend to be
hydrophobic and positively charged (i.e., weak bases) at
physiological pH. This phenomenon of multidrug resistance
(MDR) can be attributed to several different biophysical
processes: decrease in drug uptake, increase in efflux, in-
crease in drug metabolism rate, or alterations in drug-target
properties (Michelson and Slate, 1994).
Increased efflux (Inaba et al., 1979; Bradley et al., 1988;
Michelson and Slate, 1994) has been found to correlate with
the overexpression of the cell surface 170-kDa P-glycopro-
tein (Pgp), which utilizes the energy of ATP hydrolysis to
actively exclude cytotoxic drugs against their concentration
gradient, thus increasing efflux, whereas uptake is mainly
due to passive diffusion via the plasma membrane (Gottes-
man et al., 1995). To better understand this important mech-
anism of MDR, experimental methods are needed to study
the dynamic characteristics of drug efflux from sensitive as
well as drug-resistant cancer cells.
Three approaches have been used to measure drug efflux:
methods involving drug extraction (Astier et al., 1988;
Daoud and Juliano, 1989; Marquardt and Center, 1992;
Vichi and Tritton, 1992), flow cytometry (Krishan and
Ganapathi, 1980; Nooter et al., 1990; Krishan, 1990), and
flow-through detection in the culture medium (Spoelstra et
al., 1991). Even though all three approaches have been
successfully used for efflux studies on cell populations, each
has its drawbacks as well. The first one requires compli-
cated, lengthy procedures including incubation, centrifuga-
tion, and drug extraction, followed by either different chro-
matographies or fluorescent and radioactive methods for
detection. The cells are destroyed during the procedure, so
only one efflux data point for a given efflux period can be
obtained from each cell population. The second approach is
well suited for quantifying the efflux of virtually any fluo-
rescent drug in cell population studies. It provides high
temporal resolution, on the order of one sample per second.
However, flow cytometry becomes useless when the studied
drug is nonfluorescent or binding to DNA and other target
molecules quenches its fluorescence. Moreover, intracelluar
pH can affect drug fluorescence, leading to erroneous data
(Krishan, 1990). In this methodology, because the cells
flow, suspended cells are required. In the last technique, a
monolayer of cells is attached to the bottom of a chamber
and interacts with the drug-containing medium flowing over
the cells. Fluorescence or absorbance of the studied drug in
the medium obtained at the outlet of the system is measured
and compared to the one in the inlet medium. The change in
signal is related to drug uptake or efflux. This technique is
designed for cell population studies, and an optical detec-
tion scheme is required in the flow-through system. A
fluorescent drug is required when low drug concentrations
are encountered.
Based on the reported experimental approaches, contin-
uous measurement of efflux of nonfluorescent drugs on the
same cell culture in situ or assessing of efflux from a few
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cells or even a single cell is beyond the capabilities of
existing technologies.
Simple and fast detection schemes, in principle, could
also be realized by using the fact that doxorubicin (also
called Adriamycin), which is one of the most widely used
anticancer drugs in chemotherapy, and some other antican-
cer drugs are electroactive (Rao et al., 1978). Electrochem-
ical methods with mercury electrode (Rao et al., 1978) and
carbon paste electrode (Baldwin and Packett, 1981; Chaney
and Baldwin, 1982, 1985) have been used to detect doxo-
rubicin in phosphate buffer and patients’ urine. The detri-
mental effect of mercury to live cells or the requirement of
polishing the surface of a carbon paste electrode before each
measurement, however, prevented these sensing schemes
from being used for continuous cellular studies.
In the method described here, a carbon fiber (CF) micro-
electrode is used to monitor the efflux of doxorubicin from
a monolayer of cells attached to a glass coverslip. The cell
lines used were an auxotrophic mutant of Chinese hamster
ovary cells, AUXB1, and its MDR subline, CHRC5. The
efflux rates obtained from the measured concentrations
agreed well with reported results in the literature for both
the drug-sensitive and drug-resistant cell lines studied.
This approach takes advantage of the microscopic cross
section (7.5 m in diameter) and good stability of electrodes
made of carbon fiber, and the high sensitivity and sufficient
resolution of adsorptive preconcentration followed by a
reduction sweep, to monitor doxorubicin efflux from the
same monolayer of preloaded cells in situ. The preconcen-
tration step used in the measurement to adsorb doxorubicin
to the surface of the CF electrode largely increases sensi-
tivity to doxorubicin, extending the detection limit in phos-
phate-buffered saline (PBS) solution down to 0.1 nM (Yi
and Gratzl, 1993). The current temporal resolution (6 min/
data) can be further improved to about one measurement per
minute by decreasing the duration of the preconcentration
period and narrowing the voltage range for the differential
pulse voltammetry (DPV) scan. Further development of this
technique can lead to virtually continuous monitoring of
drug efflux from a few cells or even a single cancer cell and
to efflux studies on other electroactive anticancer drugs
(e.g., daunorubicin, chlorambucil, and fluorouracil).
MATERIALS AND METHODS
Materials
Carbon fiber was obtained from Zoltek Co. Pulled glass capillary tube (cat.
no. 6010; A-M System) was used as the body of the CF electrode.
Teflon-coated Ag wire (World Precision Instruments) and a 18-gauge
11⁄2-inch stainless steel hypodermic needle (Becton-Dickinson) were used
to prepare the reference and counter electrodes, respectively. The glass
coverslip (Fig. 1 A) was custom-made, with a diameter of 4 cm and a
thickness of 0.2 mm.
Crystalline doxorubicin (doxorubicin hydrochloride, Adria lot no.
89E07A; Fig. 2) was obtained from Adria Laboratories (Columbus, OH).
The efflux medium contained minimum essential  medium (MEM 
medium), 25 mM HEPES, and 10% fetal bovine serum, with a pH adjusted
to 7.2–7.4. Powdered MEM  Medium and HEPES were obtained from
GIBCO Laboratories (Grand Island, NY). Fetal bovine serum was pur-
chased from Hyclone Laboratories (Logan, Utah).
Cell lines
The cell lines used in this study were an auxotrophic mutant of Chinese
hamster ovary cells, AUXB1, and its MDR subline, CHRC5. They were
generous gifts from Dr. V. Ling (Ontario Cancer Institute, Toronto, On-
tario, Canada); they were cultured in Dr. N. A. Berger’s laboratory (Cancer
Research Center, Case Western Reserve University, Cleveland, OH). The
cells were cultured for 72 h to a density of 600-1000 cells/mm2 in the same
medium as the efflux medium at 37°C, on a glass coverslip with a diameter
of 4 cm inside a petri dish, according to usual procedures (Daoud and
Juliano, 1989).
FIGURE 1 Experimental arrangement for doxorubicin efflux measure-
ments. (A) The efflux container, made of plexiglas and covered by a plastic
cover ensuring free air exchange between inside and outside the covered
space (the cover is not shown here). The glass coverslip and the electrodes
are under the efflux medium. The depth of the medium is 1 mm. The
electrodes are placed horizontally side by side, and the CF electrode is in
the middle. The diameter of the coverslip is 4 cm. (B) Enlarged schematic
diagram of the relative positions of the carbon fiber electrode and the
effluxing cells. The arrows show the directions and patterns of diffusion of
the effluxed doxorubicin.
FIGURE 2 Chemical formula of doxorubicin, also called Adriamycin
(Arcamone, 1981, p. 21).
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Apparatus for electrochemical
detection of doxorubicin
The electrochemical cell consisted of 1) a CF working microelectrode
(diameter 7.5 m, exposed length 5 mm), 2) a AgAgCl reference
electrode (diameter 0.3 mm, length 1 cm), and 3) a stainless steel coun-
terelectrode, all immersed in the efflux medium (5 ml) in the efflux
container (Fig. 1 A). The electrodes were horizontally placed side by side
with the CF electrode in the middle. The depth of 5 ml of medium with a
cross-sectional area of 52 cm2 in the efflux container was 1 mm. The
entire setup was kept inside the solid metal Faraday cage of the BAS 100A
computer controlled potentiostat (Bioanalytical Systems) during measure-
ments to protect the signal from electrical noise from the environment. The
efflux container was partially covered by a plastic cover to prevent evap-
oration of the medium, but there was enough of an opening left at the edges
of the cover for free air exchange between the inside and outside of the
covered space. The electrodes were connected to the potentiostat with a
PA-1 preamplifier. The data were transferred after each measurement via
an RS-232 I/O interface to an Amiga-2000 computer for storage. This
computer was also used for controlling the BAS 100A to execute prepro-
grammed experiments.
The CF microelectrode was fabricated as follows: 1) a long fiber (12
cm) was sucked into a glass capillary by low vacuum; 2) the capillary was
single pulled with a PB7 Narishige microelectrode puller; 3) the extending
part of the fiber was cut to the appropriate length from the capillary tip with
a pair of scissors; 4) the electrode body was filled with mercury, into which
the stripped end (2 cm) of an insulated wire was inserted, to establish
electrical contact with the CF electrode. This simple fabrication procedure
provided a tight enough seal between the CF and the pulled tip of the glass
capillary that no adhesive sealant had to be applied inside the capillary tip.
Measurement of doxorubicin concentrations
close to the cell monolayer
A new CF electrode is used for every efflux experiment. The electrode is
kept in situ throughout the experiment without any mechanical cleaning
procedure. It is preconditioned in the efflux medium at 37°C for 4 h just
before the efflux experiment begins. The preconditioning protocol is the
same as the measurement protocol. The protocol starts with a very negative
potential (1000 mV) applied to the CF electrode for 30 s, to electro-
chemically regenerate the electrode surface before each measurement.
Then the electrode is kept open circuited for 5 min to preconcentrate
doxorubicin at the CF surface by spontaneous adsorption. Finally, a DPV
scan is performed from 300 to 1000 mV, which is the actual measure-
ment step. This protocol is repeated every 6 min. The parameters of DPV
in this entire work were 20-mV/s scan rate, 50-mV pulse amplitude, 50-ms
pulse width, and 200-ms pulse period. Current sampling/averaging was
done for 17 ms before the beginning and at the end of each pulse. Because
in DPV differential current rather than current is recorded, i/E values
are reported in the figures and text. The voltage of the working CF
electrode was measured and reported with respect to the AgAgCl reference
electrode.
Before doxorubicin is added to the cell culture for incubation, the old
culture medium is replaced by 5 ml fresh medium. The cells are then
incubated for 1 h in this medium containing 6.4 M doxorubicin at 37°C.
After incubation, the coverslip with the monolayer of drug loaded cells is
washed five times in ice-cold PBS solution (Kartner et al., 1983) within2
min and placed immediately after the last washing step into the efflux
measurement container (Fig. 1 A) with 5 ml efflux medium. The CF
electrode is placed horizontally just on top of the monolayer of the cells.
Efflux measurements begin as soon as the coverslip is in the efflux
container. The duration of the experiment is 1.5 h.
Calibration of the CF microelectrode
The temperature of the efflux medium during calibration is 37°C, and the
same measurement protocol as the one used during the efflux experiment
is applied to the CF microelectrode. The height of DPV peaks of the CF
microelectrode is a log linear function of doxorubicin concentration over a
broad range of concentrations, as shown in Fig. 3. The CF microelectrode
used for the efflux measurements is calibrated after each efflux experiment
in fresh efflux medium at 0.32 and 1.60 M drug concentrations, respec-
tively. These values are in the range of typical concentrations encountered
in efflux experiments. The two obtained DPV peak heights determine the
linear calibration to be used with respect to the logarithm of drug concen-
tration. The values of the DPV peak height from the actual efflux mea-
surement were then transformed to corresponding drug concentrations
according to this two-point calibration. Because most deactivation of the
CF electrode occurs during the first period of electrode stabilization and
very little sensitivity loss occurs later, postcalibration can be used for the
entire period of efflux measurement, without the need for extra corrections.
Normalization of the reconstructed drug efflux
To compare the results between experiments involving different cell den-
sities on the coverslip, the obtained absolute efflux rates are divided by the
density of the cells. The densities were calculated from a picture of the cell
monolayer (1.3 mm  0.9 mm) taken under microscope (Nikon Diaphot
with 10 objective lens) just before each efflux experiment.
RESULTS
Because doxorubicin contains both a quinone and a hydro-
quinone functionality as shown in Fig. 2, it can be electro-
chemically reduced or oxidized. The carbonyl side chain
can also yield a reduction current at very negative potentials
(Rao et al., 1978). Two characteristic peaks related to doxo-
rubicin were obtained with DPV in this work after adsorp-
tive preconcentration of doxorubicin on the CF surface. One
is a cathodic peak at about 630 mV, and another is an
anodic peak around 250 mV. Both peaks are useful for
analytical purposes. The positive potentials applied to ob-
tain the anodic peak (especially those above 250 mV),
however, tend to affect the surface of the CF electrode by
generating oxidized surface groups (Edmonds, 1985), lead-
ing to insufficient sensitivity for efflux measurements after
FIGURE 3 Calibration of a CF microelectrode for doxorubicin, using the
“height,” ip/E, of the cathodic DPV peaks at630 mV versus AgAgCl
in PBS solution. Peak heights were determined graphically and plotted
against a logarithmic concentration axis. The concentration range here
approximately overlaps with the one encountered in real efflux measure-
ments near the cell monolayer. The inset shows the individual calibration
sweeps, whose peak heights were used to construct the calibration curve.
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a period of time. Using the cathodic peak, a more sensitive
and stable protocol can be realized because of less damage
done by the measurement itself to the active sites on the
surface of the carbon fiber. Therefore, the cathodic peak at
around 630 mV versus AgAgCl in PBS was used for the
efflux measurements in this work. Typical DPV curves in
the cathodic range are shown in Fig. 4. To keep the sensi-
tivity of the CF electrode stable, the electrode had to be
preconditioned in the same medium as the one used for the
efflux measurement. Even when the cathodic peak is used,
the sensitivity decreases to less than half of the original
value after 4 h of conditioning, with most of this change
occurring during the first several measurement periods.
Afterward, the sensitivity of the electrode remains relatively
stable, with a 5% decrease per hour.
At higher doxorubicin concentrations (in the M range
and above) both diffusion and adsorption currents of doxo-
rubicin can be discerned in both anodic and cathodic
sweeps. When, however, the concentration of doxorubicin
decreases to below 1 M, it becomes very difficult to obtain
a detectable signal originating from diffusion current at a
CF electrode. The total doxorubicin concentration inside the
preloaded cells can be 5–200 M (Vichi and Tritton, 1992).
The concentration is much lower outside the cells and
decreases further as the CF electrode is placed further away
from the cell monolayer during efflux experiments. One of
the advantages of using a CF electrode is the spontaneous
adsorption of doxorubicin to its surface, which dramatically
increases the sensitivity of the measurement scheme when
adsorption current is used as the signal. Surface coverage
and, therefore, sensitivity can be increased by using a longer
preconcentration period. Our studies showed that adsorption
can be 97% complete after the 5-min preconcentration pe-
riod, as used in the efflux measurement protocol in this
work.
Contrary to the common practice of electrochemical
cleaning of carbon fiber electrodes at high positive voltages,
we found that a1000-mV potential with a duration of 30 s
effectively regenerated the surface of the carbon fiber be-
fore each subsequent measurement once the electrode was
stabilized. This procedure created the same initial condi-
tions for each adsorptive preconcentration step. (A positive
potential higher than 300 mV can also regenerate the
surface by oxidizing the drug, but it adversely affects the
surface of the carbon fiber, leading to a gradual decrease in
electrode sensitivity.) Reproducibility of the peak heights
for the same concentration was typically 2–3% for a stabi-
lized electrode with this cleaning protocol.
A typical calibration curve for doxorubicin is shown in
Fig. 3, using the “heights” of cathodic DPV peaks as signal
values. We found that this curve is log linear in the con-
centration range encountered in efflux studies (r2  0.98,
n  6). We hypothesize that this is due to the logarithmic
character of the adsorption isotherm of doxorubicin on
carbon fiber within the concentration range studied.
Concentration changes near the monolayer of cells in-
duced by efflux of doxorubicin from the cells have been
monitored in this work by a CF electrode, using adsorptive
preconcentration followed by DPV. Fig. 4 displays typical
DPV curves obtained during efflux measurements for the
AUXB1 and CHRC5 cell lines, respectively. The time in-
terval between subsequent DPV scans is 6 min. The arrows
indicate the direction of time increase. The curves from both
cell lines have a very clear and well-shaped peak around
630 mV, which corresponds to the position of one of the
characteristic DPV peaks for doxorubicin. The peak be-
comes higher with longer efflux time for both resistant and
sensitive cell lines at the beginning. The increase in DPV
peak height with respect to the baseline (t  0) is
FIGURE 4 Results of drug concentration measurements above mono-
layers of sensitive AUXB1 and drug-resistant CHRC5 cell lines in culture.
Electrochemical regeneration of the carbon fiber microelectrode at 1000
mV for 30 s was followed by 5 min of preconcentration in open circuit
conditions. The cathodic DPV peak at about 630 mV that was used was
obtained with a scan from 300 to 1000 mV. The time interval between
subsequent DPV scans is 6 min. The part of the DPV curves shown
indicates the concentration above the monolayer of cells at different times.
The arrows point in the direction of time increase. The increase in DPV
wave height with respect to the baseline (t  0) is proportional to the
logarithm of local doxrubicin concentration. (A) Results from AUXB1 cell
line. The cell density is 1.0  103 cells/mm2. (B) Results from CHRC5 cell
line. The cell density is 6.2  102 cells/mm2.
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proportional to the logarithm of actual local doxorubicin
concentration.
The corresponding concentrations near the monolayer of
cells versus time are shown in Fig. 5 A for both the drug-
resistant and -sensitive cell lines. The dynamic characteris-
tics for the two cell lines are different. The concentration
above the drug-sensitive cells increases at the beginning and
reaches a plateau after 1 h. The measured concentration,
however, did not begin to decrease during the experiment.
The concentration above the drug-resistant cells increases
faster than the one for the sensitive cell line and reaches a
plateau after 40 min. Then the concentration begins to
decrease until the end of the experiment.
Diffusion of the drug from the cells into the efflux me-
dium needs to be considered to reconstruct the efflux rate
from the measured concentrations. To obtain initial efflux
rates, we assumed that the efflux at the beginning, for the
first three measurement periods (18 min), does not vary
significantly. The efflux medium can be considered semi-
infinite for such a short time period (z  (DT)1/2 		 h  1
mm, where h is the depth of the medium and z is the
horizontal coordinate with the origin at the cell layer). With
these assumptions, a relationship between the measured
initial concentration time dependence and the efflux rate can
be defined (Carslaw and Jaeger, 1959, p. 75):
c
t 2Et/D (1)
where c(t) is the measured concentration, E is the constant
efflux density, D is the diffusion coefficient of doxorubicin
in the efflux medium, and t is the time from the beginning
of the experiment. Then efflux density can be obtained from
c(t) and t as follows:
E 0.5c
tD/t (2)
If S is the cell density on the coverslip, then the normalized
efflux rate for a single cell is
Ec 0.5c
tD/t/S (3)
The initial three measured concentration values within
18 min in Fig. 5 A have been used to calculate the average
initial Ec for the sensitive and resistant cell lines, respec-
tively. Cell densities were 1.0  103 cells/mm2 for sen-
sitive cells and 6.2 102 cells/mm2 for resistant cells. With
D  1.5  106 cm2/s (Shaw and Gratzl, unpublished
observations), the initial efflux rate is (3.1  0.3)  1019
mol/cell  s for the drug-resistant cell line and (6.6 0.3)
1020 mol/cell  s for the sensitive cell line, as obtained
from the initial three measurements in Figs. 4 and 5.
DISCUSSION
The time interval between subsequent measurements was 6
min in this work, allowing for a period of doxorubicin
preconcentration on the CF microelectrode of 5 min.
Adsorption reaches 97% completion after 5 min, and there-
fore it will not increase the signal significantly if longer
measurement cycles are used. When it is necessary, how-
ever, much shorter preconcentration periods can also be
selected, down to 1 min. Then the relative surface cover-
age would become 80% of the steady-state surface cov-
erage, which would still provide enough sensitivity to mea-
sure the efflux of doxorubicin from cells.
A constant efflux rate was assumed in the above diffusion
model for an initial period of 18 min to reconstruct efflux
from the measured concentrations close to the monolayer of
cells. This can be justified by the following observations: 1)
The regression coefficients for the fitted curves in Fig. 5 B
are 0.99 and 0.97, respectively. This means that the exper-
imental data agreed well with the theoretical prediction (Eq.
1), and the assumption in the diffusion model is close to the
real situation. 2) Because of the similarity between dauno-
rubicin and doxorubicin, the efflux of doxorubicin across
the cell membrane can be assumed to also consist of two
components (Spoelstra et al., 1992): carrier-mediated trans-
port approximated with a simple Michaelis-Menten-type
kinetics and passive diffusion. It is reported (Miyamoto et
al., 1990) that the amounts of drug remaining inside
AUXB1 and CHRC5 cell lines after 18 min are 90% and
25% of the initial amounts, respectively. For the sensitive
cells, the dominant efflux process is passive diffusion, and
therefore intracellular drug content decreases by only
10% during the initial 18 min. Thus it is reasonable to
assume the efflux rate to be constant during this period. For
the CHRC5 cell line, the error of the estimated initial efflux
rate induced by assuming an initially constant efflux is
FIGURE 5 Measured concentrations near the monolayer of cells versus
the efflux time. The DPV peak heights from Fig. 4 are used to calculate the
concentrations with a semilogarithmic calibration as described in Materials
and Methods. (A) Measured concentrations for the whole experiment
period. (B) Enlarged initial part of A. The solid lines are curves fitted to the
measured concentrations by the method of least squares according to Eq. 1.
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expected to be larger than for the AUXB1 cell line, because
a larger drop in intracellular drug content occurs for the
resistant cells during the same period. The standard devia-
tion of the efflux rate obtained from the initial three mea-
sured concentrations with Eq. 3 is, however, just 10% of
the mean estimated efflux. This means that efflux stays
relatively constant during the initial 18 min, even in the
resistant cell line. This also implies that if the dominant
efflux process in CHRC5 is active transport, then the
Michaelis constant, KM, is lower than the intracellular drug
concentration during most of the initial 18 min.
The concentration changes observed with the new micro-
electrode technique during the entire experimental period
can also be rationalized. The concentrations increase for
both cell lines at the beginning. This indicates a significant
efflux of doxorubicin from the cells. After 40 min from
the beginning, the concentration above the resistant cell line
reaches a maximum and then begins to decline. This means
a decrease or a halt of efflux. (It should be noted that
although the solution layer above the cells is thin, it can be
considered as a semiinfinite medium for the given D value
and time span of each experiment. This rationalizes that
once the efflux rate decreases or halts, the local concentra-
tion at the CF electrode also begins to decrease.) The
behavior of the drug-sensitive cell line is different during
this later period: the concentration increases and then
reaches a plateau, which implies a relatively steady efflux of
doxorubicin.
These results are consistent with reported results for these
two cell lines (Miyamoto et al., 1990). This finding vali-
dates the electrochemical efflux measurement technique for
drug resistance studies as introduced in this work.
There are about four to seven cells under a 100-m-long
segment of carbon fiber, as shown in Fig. 1 B. Because the
fiber diameter is 7.5 m, which is smaller than that of the
cells, the number of cells effectively contributing to the
signal measured by a 100-m-long carbon fiber is about
three to five cells, if diffusion is mainly one-dimensional.
Some nonuniformities in efflux rates by individual cells are
likely to be present, but they even out over distances similar
to the electrode length. Thus unidirectional diffusion away
from a uniform planar source is a reasonable approximation,
assuming that perturbation of the drug concentration distri-
bution by the CF microelectrode itself is negligible.
The average signal increase per 6 min measured with a
5-mm-long fiber is 10 nA/50 mV, as shown in Fig. 4.
Then signal change due to efflux from an average single cell
should be 50 pA/50mV for every 6 min. Signals of this
magnitude are still accessible by microvoltammetry. This
infers that it may be feasible to detect drug efflux from a
single cancer cell with the technique proposed in this work,
by using a 20-m-long cylindrical electrode or a microdisk
CF electrode placed close to the effluxing single cell.
Preliminary results obtained with a CF microdisk elec-
trode (Lu and Gratzl, manuscript in preparation) indeed
proved that efflux from both single AUXB1 and CHRC5
cells can be monitored with the technique introduced in this
work. This is important because heterogeneities in efflux
characteristics within one cell type (sensitive or drug-resis-
tant line) cannot be characterized without a single-cell ef-
flux measurement scheme. The technique is also ideally
suited to obtaining efflux data of high temporal resolution
from the beginning of efflux, which renders determination
of the parameters of both passive and active efflux numer-
ically better conditioned than when only techniques of low
temporal resolution are available.
It is reported that daunorubicin, marcellomycin, chloram-
bucil, fluorouracil, and methotrexate are also electroactive
(Rao et al., 1978; Chastel et al., 1989; Wang et al., 1987;
Temizer and Onar, 1988). Therefore, it is likely that efflux
of these drugs from populations as well as single cancer
cells can also be studied with this new scheme.
Voltammetry of doxorubicin at a CF microelectrode, as
described in this work, is simple to perform and has excel-
lent analytical characteristics for cell culture studies. The
advantages of this method over conventional approaches are
1) It can be used to continuously monitor the same cell
population. 2) It uses electrochemical characteristics that
may be the only chance for in situ monitoring when the drug
is nonfluorescent. 3) For continuous single-cell-level drug
efflux studies, only this technique is currently available.
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